Gibson, Dunn & Crutcher LLP represented Dianthus Therapeutics, Inc. on the placement. Dianthus Therapeutics, Inc. (NASDAQ: DNTH), a clinical-stage biotechnology company dedicated to advancing the next generation...
You must be a Standard 1 Year member to access this content.
Gibson, Dunn & Crutcher LLP advised XOMA Corporation on the expansion of its commercial royalty and milestone portfolio with the acquisition of an economic interest in...
You must be a Standard 1 Year member to access this content.
Gibson, Dunn & Crutcher LLP is representing Bora Pharmaceuticals in its acquisition of Upsher-Smith Laboratories. Bora Pharmaceuticals Co., Ltd. announced the acquisition of Upsher-Smith Laboratories, Inc., a generics manufacturer...
You must be a Standard 1 Year member to access this content.
Gibson, Dunn & Crutcher LLP represented MidOcean Partners on the matter. MidOcean Partners, a premier New York-based alternative asset manager specializing in middle-market private equity and alternative...
You must be a Standard 1 Year member to access this content.
Perella Weinberg Partners served as exclusive financial advisor and Winston & Strawn LLP acted as legal counsel to The Honey Pot Co., while Gibson, Dunn &...
You must be a Standard 1 Year member to access this content.
Gibson, Dunn & Crutcher LLP advised MidOcean Partners on the formation of MPearlRock. The Kroger Co. (NYSE: KR), its consumer product investment platform PearlRock Partners (“PearlRock”),...
You must be a Standard 1 Year member to access this content.
Houlihan Lokey and Lincoln International advised BCTS, while Gibson, Dunn & Crutcher LLP and Piper Sandler advised Investcorp on the transaction. Houlihan Lokey Capital, Inc. and...
You must be a Standard 1 Year member to access this content.
Gibson, Dunn & Crutcher LLP is advising Nextech on the matter. Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the drug discovery process...
You must be a Standard 1 Year member to access this content.
Gibson, Dunn & Crutcher LLP advised RedBird Capital Partners on RedBird IMI’s investment in Media Res, represented by Latham & Watkins LLP and Ziffren Brittenham LLP....
You must be a Standard 1 Year member to access this content.
Gibson, Dunn & Crutcher LLP advised Arlington Capital Partners on the acquisitions of Walbar Engine Components, Numet Machining Techniques, LLC and AeroCision, LLC. Arlington Capital Partners,...
You must be a Standard 1 Year member to access this content.
Gibson Dunn served as legal counsel to RoundTable. Harris Williams LLC acted as financial advisor and Taft Stettinius & Hollister served as legal counsel to EHOB....
You must be a Standard 1 Year member to access this content.
Gibson, Dunn & Crutcher LLP is advising Arrowhead Pharmaceuticals, Inc. on the offering. Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) announced the pricing of an underwritten registered offering...
You must be a Standard 1 Year member to access this content.
